0000927066-23-000231.txt : 20231218
0000927066-23-000231.hdr.sgml : 20231218
20231218184418
ACCESSION NUMBER: 0000927066-23-000231
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rodriguez Javier
CENTRAL INDEX KEY: 0001415548
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 231495143
MAIL ADDRESS:
STREET 1: 601 HAWAII ST.
CITY: EL SEGUNDO
STATE: CA
ZIP: 90245
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
DATE OF NAME CHANGE: 20121107
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
4
1
wk-form4_1702943047.xml
FORM 4
X0508
4
2023-12-14
0
0000927066
DAVITA INC.
DVA
0001415548
Rodriguez Javier
C/O DAVITA INC.
2000 16TH STREET
DENVER
CO
80202
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-12-14
4
M
0
500000
67.80
A
833299
D
Common Stock
2023-12-14
4
D
0
311581
108.80
D
521718
D
Common Stock
2023-12-14
4
F
0
82716
108.80
D
439002
D
Stock Appreciation Rights
67.80
2023-12-14
4
M
0
500000
0
D
2022-11-04
2024-11-04
Common Stock
500000
2000000
D
Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
The Stock Appreciation Rights were granted on November 4, 2019, which vested 50% each on November 4, 2022 and November 4, 2023.
/s/ Stephanie N. Berberich, Attorney-in-Fact
2023-12-18